Patient Stories

Conventional medicines treat the symptoms instead of the cause of diseases, meaning that patients must be treated throughout their lives. We are working to develop one-time treatments that target the cause of diseases.

Patients Are Counting on Us

Milton, living with ATTR amyloidosis with cardiomyopathy

Oren, Shanna and Damian, living with hereditary angioedema type 1

Nancy, living with ATTR amyloidosis with polyneuropathy

Carlos, David and Vince launched UKATPA to educate and support patients, doctors and caregivers.

Bill and Maura share their journey about Bill’s diagnosis with transthyretin (ATTR) amyloidosis.

Patients Are Counting on Us

You are leaving the Intellia Therapeutics, Inc. website.

You are leaving the
Intellia Therapeutics, Inc. website.